The global embolotherapy market size was valued at USD 3.41 billion in 2025 and is expected to reach USD 6.31 billion by 2033, at a CAGR of 8.00% during the forecast period
The market growth is largely fueled by the increasing prevalence of vascular diseases, advancements in minimally invasive procedures, and the rising adoption of image-guided embolization techniques in both developed and emerging healthcare settings
Furthermore, growing preference for targeted, safe, and effective therapeutic interventions, along with expanding awareness among clinicians and patients about embolotherapy benefits, is positioning embolotherapy as a preferred treatment option. These converging factors are accelerating the adoption of embolotherapy solutions, thereby significantly driving the market's growth